Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.

By T. Bachelot, G. Romieu, Mario Campone, V. Diéras, C. Cropet, F. Dalenc, M. Jimenez, E. Le Rhun, J. Pierga, A. Gonçalves and 6 more. The Lancet Oncology, 2013

683 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/484dbab5d3043c1830e32ba4d25cee8a6f7652bb